Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features

B Grygiel-Górniak, N Limphaibool… - Postgraduate …, 2018 - Taylor & Francis
Background: Granulomatosis with polyangiitis (GPA) presents a wide spectrum of
manifestations from the common respiratory symptoms to infrequent neurological and …

CanVasc recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitides

L McGeoch, M Twilt, L Famorca, V Bakowsky… - The Journal of …, 2016 - jrheum.org
Objective. The Canadian Vasculitis research network (CanVasc) is composed of physicians
from different medical specialties and researchers with expertise in vasculitis. One of its aims …

Serial in-office intralesional steroid injections in airway stenosis

C Bertelsen, H Shoffel-Havakuk, K O'Dell… - … –Head & Neck …, 2018 - jamanetwork.com
Importance Endoscopic dilation is the mainstay treatment strategy for subglottic and
proximal tracheal stenosis (SGS/PTS). Its major limitation is restenosis requiring repeated …

Non-malignant central airway obstruction

DB Casas, S Fernández-Bussy, E Folch… - Archivos de …, 2014 - Elsevier
The most common causes of non-malignant central airway obstruction are post-intubation
and post-tracheostomytracheal stenosis, followed by the presence of foreign bodies, benign …

Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience

B Terrier, A Dechartres, C Girard, S Jouneau… - …, 2015 - academic.oup.com
Objectives. Tracheobronchial stenosis (TBS) is noted in 12–23% of patients with
granulomatosis with polyangiitis (GPA), and includes subglottic stenosis and bronchial …

Vasculitis of the upper airways1

C Pagnoux, NE Wolter - Swiss Medical Weekly, 2012 - smw.ch
Systemic vasculitides are rare and potentially life-threatening diseases. Granulomatosis with
polyangiitis (GPA; formerly Wegener's granulomatosis) and Churg Strauss syndrome …

Systemic and local medical or surgical therapies for ear, nose and/or throat manifestations in ANCA-associated vasculitis: a systematic literature review

RM Krol, HHF Remmelts, R Klaasen, A Frima… - Journal of Clinical …, 2023 - mdpi.com
Background: Ear, nose and throat (ENT) manifestations are common in patients with
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), yet how to treat …

Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis

J Schmidt, JS Pulido, EL Matteson - Current Opinion in …, 2011 - journals.lww.com
Ocular manifestations of systemic disease: antineutrophil cy... : Current Opinion in
Ophthalmology Ocular manifestations of systemic disease: antineutrophil cytoplasmic …

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis

AWS Souza, AL Calich, HA Mariz… - Revista brasileira de …, 2017 - SciELO Brasil
The purpose of these recommendations is to guide the appropriate induction treatment of
antineutrophil cytoplasmic antibody-associated vasculitis (AAV) patients with active disease …

The efficacy of submucosal corticosteroid injection and dilatation in subglottic stenosis of different aetiology

M Wierzbicka, M Tokarski, M Puszczewicz… - The Journal of …, 2016 - cambridge.org
Objective: To determine the long-term efficacy of submucosal corticosteroid injection plus
dilatation for subglottic stenosis as a single modality treatment in granulomatosis with …